Aurora Cannabis (TSE:ACB) Releases Quarterly Earnings Results

Aurora Cannabis (TSE:ACB) released its quarterly earnings results on Thursday. The company reported C$0.05 earnings per share for the quarter, FiscalAI reports. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. The firm had revenue of C$86.02 million during the quarter.

Aurora Cannabis Trading Down 0.3%

Shares of ACB stock traded down C$0.02 on Thursday, reaching C$7.29. 1,353,675 shares of the stock were exchanged, compared to its average volume of 420,103. The stock has a market cap of C$451.67 million, a PE ratio of -3.76 and a beta of 0.64. Aurora Cannabis has a one year low of C$3.59 and a one year high of C$8.75. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48. The stock has a 50 day moving average price of C$5.76 and a 200 day moving average price of C$4.95.

Wall Street Analysts Forecast Growth

ACB has been the subject of a number of research reports. ATB Cormark Capital Markets raised their target price on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a “tender” rating in a research note on Tuesday, October 6th. TD Securities cut shares of Aurora Cannabis from a “strong-buy” rating to a “strong sell” rating in a research report on Tuesday. BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a research note on Wednesday, August 5th. Finally, TD lowered shares of Aurora Cannabis from a “buy” rating to a “sell” rating and reduced their target price for the stock from C$8.00 to C$7.80 in a research report on Wednesday. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of C$6.60.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.